(Q58811258)
Statements
rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM (English)
P V Carroll
M Umpleby
G S Ward
S Imuere
E Alexander
P H Sönksen
D L Russell-Jones
1 September 1997